Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma

PURPOSE: TAK-639 is a topical, nine-amino acid, synthetic, C-type natriuretic peptide analog in Phase 1 development for the treatment of ocular hypertension (OHT) and primary open-angle glaucoma (POAG). TAK-639 is postulated to lower intraocular pressure (IOP) through a novel mechanism of action (MO...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Patrick, Cohen, Alisa, Uddin, Sharif, Epelbaum, Laura, Josiah, Serene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093107/
https://www.ncbi.nlm.nih.gov/pubmed/32256046
http://dx.doi.org/10.2147/OPTH.S242932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093107/
https://www.ncbi.nlm.nih.gov/pubmed/32256046
http://dx.doi.org/10.2147/OPTH.S242932

Ejemplares similares